Infratil Independent Valuation Update - 30 June 2024
1994
2024
As at 30 June 2024
Infratil Independent Valuation Update
1
Overview
A number of Infratil's investments have independentvaluations completedas at 30 June,withthoseresults summarised below.
CDC, Longroad, Galileo, Mint, Qscan and RetireAustralia values below reflect the midpoint of the 30 June independent valuations. CDC’s key valuation
methodologies and assumptions were presented as part the NZX valuation announcement on 4 July 2024.
Key valuation methodologies and assumptions underpinning the remaining independent valuations are summarised on the following page and remain
consistent with the 31 March 2024 valuations
1
, except for Longroad (refer below), and an update for the inclusion of storage for Galileo.
The decrease in the Longroad independent valuation is largely attributable to an increase in discount rates outweighing minor positive updates to operating
forecasts.
Independent Valuation Update
Portfolio Companies (NZ$Millions)31 March 202430 June 2024
CDC$4,419.7$4,950.0
Longroad Energy$1,952.0$1,831.0
Galileo$240.7$241.9
Mint Renewables$2.0$13.3
Qscan Group$411.9$424.6
RetireAustralia$464.4$492.9
1. Valuation methodologies and assumptions for 31 March 2024 included here: Infratil FY24 Annual Results Presentation (nzx.com)
2
Primary valuation methodology: Sum-of-the-parts
reflecting:
–DCF using FCFE for operating assets, under-
construction projects, and near-term development
projects (projects that are expected to achieve
FNTP within the next 3 calendar years)
–Multiples approach for long-term development
projects (discounted on FNTP year)
–An element of platform value (goodwill)
Forecast period: ~40 years (2065)
Enterprise value: US$6,380m
Equity value: US$2,999m
1
Key valuation assumptions
Risk free rate: 4.6% (Mar 24: 4.4%)
Asset beta: 0.39 - 0.37 (Mar 24: 0.33 / 0.33)
Cost of equity: 8.75 – 9.00% (Mar 24: 8.25% / 8.5%)
for operating and under-construction assets with an
additional premium risk premium of 0.75% – 1.75%
applied to near-term development assets and 15% for
long-term development pipeline and platform
Terminal value: N/A (finite life assets)
Near-term (3 years) development pipeline: 3,859MW
(Mar 24: 3,859MW)
Long-term development pipeline (5 years): 21,039MW
(Mar 24: 20,052MW)
Multiple for long-term development projects:
US$150/kW (Mar 24: US$175/kW)
Remaining platform value assessed to be around
~8% of total enterprise value
Longroad (37.3%) – US$1,113m
(NZ$1,831m)
Galileo (40%) – €138m (NZ$242m)
Primary valuation methodology: Transaction
multiples for more advanced projects and cost
for entry-stage projects
Equity value: €343.9m
Key valuation assumptions
Risk free rate: n/a (DCF methodology not
adopted)
Asset beta: n/a (DCF methodology not adopted)
Multiples for development projects that are
‘ready to build’ range from €50-400k/MW
depending on country and technology type (i.e.
solar, wind or standalone battery storage)
The valuer assigns a discount (~10-95%) to the
multiple that it considers appropriate as the
project moves towards ‘ready to build’ stage. For
projects that are early to mid-stage of the
development lifecycle, only a small percentage
of the ‘ready to build’ value is captured with the
majority of value being recognised as projects
get close to ‘ready to build’ stage.
Platform premium of ~1% applied
Independent valuation summary
FX Rates: NZD/USD: 0.6080 NZD/EUR: 0.5687 NZD/AUD: 0.9139 NZD/GBP: 0.4814
1. Longroad Equity Value adjusted for committed but uncalled capital included in the independent valuation
Qscan (57.6%) – A$388m (NZ$425m)RetireAustralia (50%) – A$450m (NZ$493m)
Primary valuation methodology: DCF using
FCFF (with a cross check to comparable
companies and precedent transactions)
Forecast period: 40 years (2064)
Enterprise value: A$1,111.0m
Equity value: A$900.9m
Key valuation assumptions
Risk free rate: 3.95%
Asset beta: 0.89
Weighted average cost of capital: 11.55%
(blended rate)
The valuer adopts different discount rates for
each segment (i.e. existing, brownfield and
greenfield developments) having regard to the
different risk profiles
Terminal growth rate: 2.5%
Primary valuation methodology: DCF using
FCFE (with a cross check to comparable
companies and precedent transactions)
Forecast period: 10 years (2034)
Enterprise value: A$915.9m
Equity value: A$673.4
Key valuation assumptions
Risk free rate: 3.95%
Asset beta: 0.80
Cost of equity: 13.85%
Terminal growth rate: 3.1%
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- KFL — Kingfish Limited: Kingfish 2024 Annual Report2024-06-14
“In the prior year, the share prices of New Zealand’s retirement village companies (including Summerset) came under indiscriminate pressure due to broader challenges facing the local housing market as prices and sales volumes both fell. In the year to 31 March 2024, national h…”